Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$13.01 - $15.77 $484,830 - $587,684
37,266 New
37,266 $516,000
Q4 2023

Feb 14, 2024

SELL
$11.67 - $20.73 $205,625 - $365,262
-17,620 Reduced 46.68%
20,126 $325,000
Q2 2023

Aug 14, 2023

SELL
$14.1 - $19.83 $1.36 Million - $1.91 Million
-96,433 Reduced 71.87%
37,746 $606,000
Q1 2023

May 15, 2023

BUY
$9.09 - $19.45 $696,393 - $1.49 Million
76,611 Added 133.08%
134,179 $2.34 Million
Q4 2022

Feb 14, 2023

SELL
$6.45 - $12.07 $1.22 Million - $2.29 Million
-189,481 Reduced 76.7%
57,568 $531,000
Q3 2022

Nov 14, 2022

BUY
$7.86 - $12.91 $757,145 - $1.24 Million
96,329 Added 63.91%
247,049 $2.13 Million
Q2 2022

Aug 15, 2022

SELL
$7.06 - $13.97 $424,228 - $839,443
-60,089 Reduced 28.5%
150,720 $1.23 Million
Q1 2022

May 16, 2022

BUY
$12.15 - $35.28 $2.56 Million - $7.44 Million
210,809 New
210,809 $2.56 Million
Q1 2021

May 17, 2021

SELL
$41.56 - $59.88 $239,510 - $345,088
-5,763 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$36.08 - $56.47 $207,929 - $325,436
5,763 New
5,763 $310,000
Q4 2019

Feb 14, 2020

SELL
$18.96 - $29.84 $1.5 Million - $2.36 Million
-78,928 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$19.12 - $26.24 $1.18 Million - $1.61 Million
61,547 Added 354.11%
78,928 $1.51 Million
Q2 2019

Aug 14, 2019

SELL
$19.57 - $24.1 $2.89 Million - $3.56 Million
-147,916 Reduced 89.48%
17,381 $381,000
Q1 2019

May 15, 2019

BUY
$12.14 - $20.46 $923,307 - $1.56 Million
76,055 Added 85.22%
165,297 $3.38 Million
Q4 2018

Feb 14, 2019

BUY
$11.24 - $18.5 $92,640 - $152,477
8,242 Added 10.18%
89,242 $1.13 Million
Q3 2018

Nov 14, 2018

BUY
$12.5 - $15.38 $656,250 - $807,450
52,500 Added 184.21%
81,000 $1.24 Million
Q2 2018

Aug 14, 2018

BUY
$7.99 - $14.05 $227,715 - $400,425
28,500 New
28,500 $374,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.07B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.